Upfront Diagnostics: Funding, Investors & Team (Oct 2026)
Upfront diagnostics was founded in November 2017 in Cambridge, United Kingdom. We are a group of Cambridge students and entrepreneurs focused on discovering biomarkers that can be applied to improve medical diagnosis. We have built the first blood test for large vessel occlusion stroke diagnosis called "LVOne", enabling a faster and more accurate stroke diagnosis that improves treatment and can help clinicians saving lives. We believe in excellence, bringing products that help clinicians, paramedics and nurses to deliver a better care to patients in more cost-effective ways. #TimeisLife
Upfront Diagnostics has raised $6.3M across 2 funding rounds on record, the most recent an undisclosed round of $4.3M announced in May 2025.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Upfront Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2025.
Upfront Diagnostics Funding Rounds
Upfront Diagnostics raised $2.0M in a Seed announced in Jun 2023.
1.9 years later, an undisclosed round of $4.3M was announced in May 2025.
Upfront Diagnostics Founders and Leadership Team
Contact details for the Upfront Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →Upfront Diagnostics Funding Compared to Other Health Care Startups
Upfront Diagnostics' latest round of $4.3M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Upfront Diagnostics in Health Care and Cambridge
Companies Similar to Upfront Diagnostics
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Upfront Diagnostics Funding FAQs
What does Upfront Diagnostics do?
Upfront diagnostics was founded in November 2017 in Cambridge, United Kingdom. We are a group of Cambridge students and entrepreneurs focused on discovering biomarkers that can be applied to improve medical diagnosis. We have built the first blood test for large vessel occlusion stroke diagnosis called "LVOne", enabling a faster and more accurate stroke diagnosis that improves treatment and can help clinicians saving lives. We believe in excellence, bringing products that help clinicians, paramedics and nurses to deliver a better care to patients in more cost-effective ways. #TimeisLife
How much funding has Upfront Diagnostics raised?
Upfront Diagnostics has raised $6.3M across 2 rounds on record. The most recent is an undisclosed round of $4.3M announced in May 2025.
When did Upfront Diagnostics last raise funding?
Upfront Diagnostics' most recent funding round on record is an undisclosed round of $4.3M, announced in May 2025.
Who founded Upfront Diagnostics?
FundedIQ lists Gonzalo Ladreda (Founder) at Upfront Diagnostics.
Where is Upfront Diagnostics headquartered?
Upfront Diagnostics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Upfront Diagnostics have?
Upfront Diagnostics is in the 1-10 employee band.
How does Upfront Diagnostics' funding compare to other Health Care startups?
Upfront Diagnostics' latest round of $4.3M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.
About FundedIQ's Upfront Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Upfront Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.